Bacil Pharma Ltd
Fri 11/09/2026,16:1:0 | BSE : BACPHAR
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 19.24
Previous Close
₹ 18.46
Volume
72699
Mkt Cap ( ₹ Cr)
₹ 27.82
High
₹ 19.38
Low
₹ 18.83
52 Week High
₹ 61.80
52 Week Low
₹ 10.65
Book Value Per Share
₹ 17.54
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Bacil Pharma Ltd
Your Vote -
Buy
50.00%
Hold
33.33%
Sell
16.67%
50.00%
6 users have voted
Option Chain
Analyzes market sentiment, predicts Bacil Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Bacil Pharma - Reg. 34 (1) Annual Report.
-
Bacil Pharma - Notice Of Annual General Meeting To Be Held On 23Rd September, 2026
-
Bacil Pharma - Intimation For Book Closure
-
Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th August, 2026
-
Bacil Pharma - Board Meeting Intimation for Bacil Pharma Limited (\The Company\) Will Be Held On 29Th August, 2026
-
Bacil Pharma - Appointment Of Director
-
Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026
-
Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 25Th August 2026
-
Bacil Pharma - Un-Audited Financial Results For The Quarter Ended 30Th June, 2026
-
Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August, 2026
-
Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026
-
Bacil Pharma - Announcement Under Regulation 30, LODR
-
Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Bacil Pharma - Attached Resignation Of Directors As Query Raised From BSE
-
Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Raising of Funds
-
Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations
-
Bacil Pharma - Intimation Regarding Approval Of Name For Proposed Wholly-Owned Subsidiary
-
Bacil Pharma - Board Meeting Intimation for We Hereby Inform You That A Meeting Of The Board Of Directors Of The Company Is S
-
Bacil Pharma - Intimation For Appointment Of Independent Director
-
Bacil Pharma - Withdrawal Of Intimation For Appointment Of Independent Directors
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Bacil Pharma - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 26Th June, 2026 Pursuant To
-
Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obliga
-
Bacil Pharma - Intimation Of Proposed Incorporation Of Wholly-Owned Subsidiary
Key fundamentals
Evaluate the intrinsic value of Bacil Pharma Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 24.8125 | 25.5952 | 1.3117 | 1.12 | 1.2575 |
| Liabilities | 24.8125 | 25.5952 | 1.3117 | 1.12 | 1.2575 |
| Equity | 13.9702 | 13.9702 | 6.5272 | 6.5271 | 6.5271 |
| Gross Profit | -0.245 | -0.2532 | -0.1875 | -0.2138 | -3.9138 |
| Net Profit | 1.5555 | 0.4041 | -0.0589 | -0.1018 | -3.8598 |
| Cash From Operating Activities | 0.7116 | 0.4008 | -0.0029 | -0.1474 | -4.0089 |
| NPM(%) | 0 | 0 | 0 | 0 | 0 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.245 | 0.2532 | 0.1875 | 0.2138 | 3.9138 |
| ROE(%) | 6.17 | 1.6 | -0.23 | -0.4 | -15.33 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Bacil Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 846.15 | -1.01 | 21.35 | 11.06 | -26.19 | 0.59 |
| Lotus Eye Hospital and Institute Ltd | 113.25 | 1.89 | 1627.14 | 40.30 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 15.11 | 0.20 | 0.00 | 83.68 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 695.50 | -2.30 | 0.00 | 43.18 | -363.14 | 0.00 |
Company Info
Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.
Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.
Read More
Parent Organisation
Bacil Pharma Ltd.
Founded
08/05/1987
Managing Director
NSE Symbol
FAQ
The current price of Bacil Pharma Ltd is
The 52-week high for Bacil Pharma Ltd is
The market capitalization of Bacil Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Bacil Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Bacil Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Bacil Pharma Ltd shares.
The CEO of Bacil Pharma Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
